Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asterixis induced by carbamazepine therapy.

H Rittmannsberger1, F Leblhuber

  • 1Department of Psychiatry, Wagner-Jauregg-Krankenhaus, Linz, Austria.

Biological Psychiatry
|August 15, 1992
PubMed
Summary

Asterixis, a neurological side effect, can occur with psychotropic medications like carbamazepine (CBZ). This neurotoxicity may happen even at lower doses when combined with drugs such as lithium or clozapine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids.

Journal of neural transmission (Vienna, Austria : 1996)·2021
Same author

Treatment of patients with geriatric depression with repetitive transcranial magnetic stimulation.

Journal of neural transmission (Vienna, Austria : 1996)·2019
Same author

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics.

International journal of psychiatry in clinical practice·2014
Same author

Topiramate Treatment of Essential Tremor in a Patient with Cognitive Deficits.

Case reports in neurology·2010
Same author

Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease.

Free radical research·2008
Same author

Homocysteine but not neopterin declines in demented patients on B vitamins.

Journal of neural transmission (Vienna, Austria : 1996)·2006

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Clinical Neurology

Background:

  • Asterixis is infrequently reported as a side effect of psychopharmacologic treatment.
  • Investigating potential neurotoxic effects of psychotropic drug combinations is crucial for patient safety.

Observation:

  • Four patients developed asterixis during treatment with psychotropic medications.
  • Asterixis emerged upon initiation or dose increase of carbamazepine (CBZ).
  • Notably, CBZ dosage and serum levels were not elevated in these cases.

Findings:

  • Carbamazepine (CBZ), particularly when combined with lithium or clozapine, can trigger asterixis.
  • Neurotoxicity manifesting as asterixis may occur at low to moderate CBZ dosages in specific patient populations.
  • This suggests a potential drug interaction leading to an easily overlooked neurological sign.

Implications:

  • Clinicians should be vigilant for asterixis as a sign of neurotoxicity in patients on psychotropic drug combinations.
  • The findings highlight the importance of considering drug interactions, even at sub-therapeutic levels, when prescribing psychotropic agents.
  • Further research into the mechanisms of CBZ-induced neurotoxicity in conjunction with other psychotropics is warranted.

Related Experiment Videos